Gilead Australia Medical Fellowships open for 2027 applications

Applications for the 2027 Gilead Australia Medical Fellowships are open and will remain so until 14 May 2026, with recipients slated for announcement in July.

The Gilead Australia Medical Fellowships have opened applications for their 2027 cycle. The program has supported Australian-led applied clinical research for more than fifteen years. It has invested over four million Australian dollars into projects intended to improve patient outcomes in real-world clinical settings. The fellowships prioritize work that can translate scientific findings into better healthcare delivery. Key details: - Applications for the 2027 fellowship cycle are open and will remain open until 14 May 2026; recipients are slated for announcement in July. - The program has provided more than four million Australian dollars in funding since its inception, including commitments through 2026. - Priority disease areas are HIV, chronic viral hepatitis, and hematological malignancies. - The fellowship emphasizes applied research designs such as prospective observational studies, implementation science, and health services research. - Applicants are expected to engage health system stakeholders and projects focusing on health equity and culturally tailored interventions for Indigenous and underserved populations are encouraged. - The scheme supports multidisciplinary teams and mentorship, and Gilead positions the fellowship as part of its wider global activities across more than 35 countries. Summary: The fellowship has a sustained record of supporting applied clinical research that aims to inform practice and strengthen health systems. The 2027 cycle is now open, with a closing date of 14 May 2026 and recipients to be announced in July. The program continues to focus on projects with clear pathways to clinical impact in its stated priority areas.